Similarly, Erdem et al. analyzed the diagnostic accuracy of PET-CT PSMA in intermediate- and high-risk prostate cancer patients before radical prostatectomy, reporting a sensitivity of 0.60 and specificity of 0.96 in a per-patient analysis, but without assessing correlation or agreement [11]. Here, FOLH1 is linked to prostate cancer.